Shire’s Bid for Baxalta: beware the “ Synergies,” PharmExec, 08 September 2015

In this article on Synergies Paul Heugh argued: “Shire and Baxalta will need to decide whether to choose one company culture to adopt, create a wholly new culture or adopt a blend of both…These factors are all easily overlooked or underplayed amid the excitement of the affair and post-deal euphoria.”

Full article on PharmaExec.com